Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 9.9 CNY -0.9% Market Closed
Market Cap: 4.3B CNY

Hunan Fangsheng Pharmaceutical Co Ltd's latest stock split occurred on May 5, 2016

The company executed a 3-for-1 stock split, meaning that for every share held, investors received 3 new shares.

Before the split, Hunan Fangsheng Pharmaceutical Co Ltd traded at 48.63 per share. Afterward, the share price was about 16.1521.

The adjusted shares began trading on May 5, 2016. This was Hunan Fangsheng Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Apr 17, 2015.

Last Splits:
May 5, 2016
3-for-1
Apr 17, 2015
13-for-10
Pre-Split Price
14.5687 48.63
Post-Split Price
16.1521
Before
After
Last Splits:
May 5, 2016
3-for-1
Apr 17, 2015
13-for-10

Hunan Fangsheng Pharmaceutical Co Ltd
Stock Splits History

Hunan Fangsheng Pharmaceutical Co Ltd Stock Splits Timeline
May 5, 2016
May 5, 2016
Split 3-for-1
x3
Pre-Split Price
14.5687 48.63
Post-Split Price
16.1521
Before
After
Apr 17, 2015
Apr 17, 2015
Split 13-for-10
x1.3
Pre-Split Price
11.1408 48.5001
Post-Split Price
11.3602
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.4B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15.04 CNY
Undervaluation 34%
Intrinsic Value
Price
Back to Top